Jay T Flatley is Chairman and Acting CEO of Zymergen Inc.. Currently has a direct ownership of 0 shares of ZY, which is worth approximately $0. The most recent transaction as insider was on Oct 19, 2022, when has been sold 144,789 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

JAY T FLATLEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 19 2022
SELL
Sale (or disposition) back to the issuer
-
144,789 Reduced 100.0%
0 Common Stock
Nov 17 2021
BUY
Open market or private purchase
$1,000,000 $10.0 p/Share
100,000 Added 40.85%
144,789 Common Stock
Apr 26 2021
BUY
Conversion of derivative security
-
44,789 Added 50.0%
44,789 Common Stock

Also insider at

ILMN
ILLUMINA, INC. Healthcare
DNLI
Denali Therapeutics Inc. Healthcare
RIVN
Rivian Automotive, Inc. Consumer Cyclical
JTF

Jay T Flatley

Chairman and Acting CEO
San Diego, CA

Track Institutional and Insider Activities on ZY

Follow Zymergen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZY shares.

Notify only if

Insider Trading

Get notified when an Zymergen Inc. insider buys or sells ZY shares.

Notify only if

News

Receive news related to Zymergen Inc.

Track Activities on ZY